Obstetric outcome in systemic lupus erythematosus

https://doi.org/10.1016/S0049-0172(95)80030-1Get rights and content

Abstract

A prospective study was performed to investigate the fetal and maternal outcome of 108 pregnancies in 90 lupus patients. The protocol was based on shared care of the patients by a rheumatologist and an obstetrician, with input from a hematologist, if necessary. Lupus flares were treated with low-dose prednisolone, azathioprine and hydroxychloroquine. The live birth rate was increased from 31% in the patients' previous obstetric history to 82%. A high incidence of prematurity was observed (43%). Lupus patients with secondary antiphospholipid syndrome presented a higher risk for fetal loss (P = .006). Flares occurred in 57% of the pregnancies, but most were mild (skin and joints). Flare during pregnancy did not increase the risk of fetal loss. We believe that careful monitoring and management of the lupus pregnancy has substantially improved the fetal outcome.

References (43)

  • HayslettJ.P.

    The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome

    Am J Reprod Immunol

    (1992)
  • LoveP.E. et al.

    Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus(SLE) and in non-SLE disorders

    Ann Intern Med

    (1990)
  • LockshinM.D. et al.

    Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

    N Engl J Med

    (1985)
  • TanE.M. et al.

    The 1982 revised criteria for the classification of systemic lupus erythematosus

    Arthritis Rheum

    (1982)
  • BuchananN.M.M. et al.

    A study of 100 high-risk lupus pregnancies

    Am J Reprod Immunol

    (1992)
  • FragaA. et al.

    Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus

    J Rheumatol

    (1974)
  • EllisF.A. et al.

    Lupus erythematosus associated with pregnancy and menopause

    Arch Dermatol Syph

    (1952)
  • FriedmanE.A. et al.

    Pregnancy and lupus erythematosus

    Obstet Gynecol

    (1956)
  • EstesD. et al.

    Systemic lupus erythematosus and pregnancy

    Clin Obstet Gynecol

    (1965)
  • BuchananN.M.M. et al.

    Practical management of pregnancy in systemic lupus erythematosus

    Fetal Mat Med Rev

    (1993)
  • Cited by (121)

    • Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis

      2018, Joint Bone Spine
      Citation Excerpt :

      SLE pregnancies are characterized by an increased risk of disease flare leading to increased morbidity and mortality [1–3]. SLE can impact pregnancy outcomes with increased incidence of obstetrical complications such as stillbirth, spontaneous abortion, premature delivery, intrauterine growth restriction (IUGR), and preeclampsia, as well as neonatal complications including congenital heart block and neonatal lupus [4–7]. The beneficial effects of antimalarial drugs on disease activity in patients with SLE were published thirty years ago [8–11].

    • Pregnancy and autoimmune disease, reproductive and hormonal issues

      2018, Dubois' Lupus Erythematosus and Related Syndromes
    • Pregnancy in Women with SLE

      2013, Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition
    View all citing articles on Scopus
    View full text